Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Active targeting of orthotopic glioma using biomimetic liposomes co-loaded elemene and cabazitaxel modified by transferritin
Jie Li, Huamin Zeng, Yu You, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
Colloids and Surfaces B Biointerfaces (2022) Vol. 221, pp. 112999-112999
Open Access | Times Cited: 75
Liposomes for the Treatment of Brain Cancer—A Review
R. Raju, Waad H. Abuwatfa, William G. Pitt, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1056-1056
Open Access | Times Cited: 41
Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
Rui Sun, Jingyue Dai, Mingjian Ling, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Screening and modification of (+)-germacrene a synthase for the production of the antitumor drug (−)-β-elemene in engineered Saccharomyces cerevisiae
Yuhan Hu, Qin Zhang, Xue Bai, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135455-135455
Closed Access | Times Cited: 14
Targeted Glioma Therapy—Clinical Trials and Future Directions
A. B. Shikalov, Igor Koman, Natalya M. Kogan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Hopping the Hurdle: Strategies to Enhance the Molecular Delivery to the Brain through the Blood–Brain Barrier
Sinnead Anne Cogill, Jae-Hyeok Lee, Min‐Tae Jeon, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 789-789
Open Access | Times Cited: 8
Targeted drug delivery systems for elemene in cancer therapy: The story thus far
Huan Tian, Feng Zhao, Qing-rui Qi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115331-115331
Open Access | Times Cited: 21
Purpurolide C-based microneedle promotes macrophage-mediated diabetic wound healing via inhibiting TLR4-MD2 dimerization and MYD88 phosphorylation
Yitong Liu, Gui‐Yang Xia, Yingyi Chen, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 5060-5073
Open Access | Times Cited: 19
Diagnostic and Therapeutic Approaches for Glioblastoma and Neuroblastoma Cancers Using Chlorotoxin Nanoparticles
Taahirah Boltman, Mervin Meyer, Okobi E. Ekpo
Cancers (2023) Vol. 15, Iss. 13, pp. 3388-3388
Open Access | Times Cited: 17
Progress and Challenges in the Diagnosis and Treatment of Brain Cancer Using Nanotechnology
Yogita Ale, Nidhi Nainwal
Molecular Pharmaceutics (2023) Vol. 20, Iss. 10, pp. 4893-4921
Closed Access | Times Cited: 17
Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
Paul S. Kawak, Nour M. Al Sawaftah, William G. Pitt, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13262-13262
Open Access | Times Cited: 16
Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease
Shalu Singh, Rahul Shukla
AAPS PharmSciTech (2023) Vol. 24, Iss. 7
Closed Access | Times Cited: 16
An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6
Development of modern Chinese medicine guided by molecular compatibility theory
Lifeng Luo, Jieru Zhou, Xiaonan Liu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Current development of cabazitaxel drug delivery systems
Boyang Sun, Jonathan F. Lovell, Yumiao Zhang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 2
Closed Access | Times Cited: 27
Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
Oxana Semyachkina‐Glushkovskaya, Alexander Shirokov, Inna Blokhina, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 36-36
Open Access | Times Cited: 24
Low-Level Laser Treatment Induces the Blood-Brain Barrier Opening and the Brain Drainage System Activation: Delivery of Liposomes into Mouse Glioblastoma
Oxana Semyachkina‐Glushkovskaya, Denis E. Bragin, Olga Bragina, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 567-567
Open Access | Times Cited: 15
Cabazitaxel-nano delivery systems as a cutting-edge for cancer therapy
Mehrab Pourmadadi, Amirhossein Ghaemi, Meysam Shaghaghi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104338-104338
Closed Access | Times Cited: 14
The Extraction, Determination, and Bioactivity of Curcumenol: A Comprehensive Review
Jie Li, Yitian Sun, Guohua Li, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 656-656
Open Access | Times Cited: 5
Liposomal Nanomaterials: A Rising Star in Glioma Treatment
Yu Gan, Yingying Yu, Huizhe Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6757-6776
Open Access | Times Cited: 5
Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
Qixiong Lin, Yueyou Peng, Yanyan Wen, et al.
Beilstein Journal of Nanotechnology (2023) Vol. 14, pp. 262-279
Open Access | Times Cited: 11
Unleashing the potential: integrating nano-delivery systems with traditional Chinese medicine
Jianhua Zou, Meng Li, Ziwei Liu, et al.
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8791-8806
Closed Access | Times Cited: 4
Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases
Kaiting Miao, Xue Xia, Yan Zou, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 4
Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
Qian Wang, Xiumin Xue, Zhichao Chen, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
Page 1 - Next Page

Scroll to top